Jane Ryan's most recent trade in Neuphoria Therapeutics Inc. was a trade of 8,537 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 20, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neuphoria Therapeutics Inc | Jane Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,537 | 15,550 | - | - | Restricted Stock Units | |
| Neuphoria Therapeutics Inc | Jane Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2025 | 6,783 | 7,013 | - | - | Restricted Stock Units |